Outpatient prescriptions for the drug increased 71% after the announcement, but the FDA later approved it only for folate deficiency ...

The FDA declined to endorse leucovorin as a treatment for autism, but approved the drug to treat cerebral folate deficiency, ...

After leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about ...

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...

The drug was approved to treat cerebral folate deficiency, a rare genetic condition.

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration announced Tuesday that it has approved expanded use of leucovorin calcium to treat a rare ...

Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...

The FDA narrowed leucovorin's use to a rare disorder, a major shift after Trump and RFK Jr. promoted it for autism.

The Food and Drug Administration approved a decades-old prescription vitamin called leucovorin as the first treatment for a rare genetic disorder in certain adults and children. The move comes months ...

The Trump administration announced late last month "bold actions to tackle the autism epidemic.” President Trump said there was a possible link between acetaminophen, the active ingredient in Tylenol, ...

Scientists have learned more about the genetic factors that may underlie double-jointedness, also known as hypermobility, and diseases that affect connective tissue called hypermobile Ehlers-Danlos ...